Incross Co.,Ltd. Logo

Incross Co.,Ltd.

A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.

216050 | KO

Overview

Corporate Details

ISIN(s):
KR7216050005
LEI:
Country:
South Korea
Address:
서울특별시 관악구 남부순환로 1926 (경동제약빌딩 5층,8층), 관악구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Incross Co., Ltd. is a digital marketing company specializing in data-driven advertising solutions. The company develops and operates a portfolio of proprietary platforms, including 'Dawin,' a leading video ad network in South Korea, and 'T deal,' an AI-powered commerce service leveraging SK Telecom customer data. Incross also offers 'ASUM,' a big data marketing platform integrating SK Group's advertising businesses, and 'Stellyze,' an AI-based content marketing platform. The firm provides comprehensive services from strategic media planning and campaign execution to performance analysis, supported by its dedicated R&D center and the Incross Data Lab (IDL) for advanced audience insights and targeting.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
Related Party Transaction
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 9.0 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 2.0 MB
2025-08-14 00:00
Environmental & Social Information
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 2.1 KB
2025-08-05 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 14.7 KB
2025-08-05 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.7 KB
2025-05-30 00:00
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 109.9 KB
2025-05-20 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.2 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.0 MB
2025-05-08 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.2 KB
2025-05-07 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 14.7 KB
2025-05-07 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.7 KB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.6 KB
2025-03-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 28.0 KB
2025-03-27 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.9 KB
2025-03-18 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 466.7 KB

Automate Your Workflow. Get a real-time feed of all Incross Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Incross Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Incross Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Material Group inc. Logo
A professional services firm offering PR consulting, marketing, and brand strategy.
Japan
156A
Medesis Pharma S.A. Logo
Develops therapies for CNS disorders and radiation exposure via a drug delivery platform.
France
ALMDP
Medicofarma Biotech Spolka Akcyjna Logo
A biotech R&D company developing innovative drugs and devices with a focus on oncology therapies.
Poland
MDB
Medpace Holdings, Inc. Logo
Global CRO providing full-service clinical development to biotech, pharma & medical device industries.
United States of America
MEDP
Develops biomarker-based precision therapies for oncology and other incurable diseases.
South Korea
235980
Medrx Co.,Ltd. Logo
Develops and licenses transdermal drug delivery systems for the pharmaceutical industry.
Japan
4586
Developing nanomedicines and drug delivery systems for oncology, hematology, and diagnostics.
Malaysia
N/A
A holding company driving regional growth by supporting construction, HR, and nursing care businesses.
Japan
7369
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden
IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America
M3D

Talk to a Data Expert

Have a question? We'll get back to you promptly.